Oxidative stress mitigation by antioxidants-an overview on their chemistry and influences on health status

AM Pisoschi, A Pop, F Iordache, L Stanca… - European Journal of …, 2021 - Elsevier
The present review paper focuses on the chemistry of oxidative stress mitigation by
antioxidants. Oxidative stress is understood as a lack of balance between the pro-oxidant …

[HTML][HTML] Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome

JE Martinez, DD Kahana, S Ghuman… - Frontiers in …, 2021 - frontiersin.org
The study of the intestinal or gut microbiome is a newer field that is rapidly gaining attention.
Bidirectional communication between gut microbes and the host can impact numerous …

[HTML][HTML] An inflammation-centric view of neurological disease: beyond the neuron

SD Skaper, L Facci, M Zusso, P Giusti - Frontiers in cellular …, 2018 - frontiersin.org
Inflammation is a complex biological response fundamental to how the body deals with
injury and infection to eliminate the initial cause of cell injury and effect repair. Unlike a …

[HTML][HTML] Neurotoxicity of pesticides–A link to neurodegeneration

B Vellingiri, M Chandrasekhar, SS Sabari… - Ecotoxicology and …, 2022 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder which mainly targets motor
symptoms such as tremor, rigidity, bradykinesia and postural instability. The physiological …

[HTML][HTML] Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease

O Karayel, SV Winter, S Padmanabhan, YI Kuras… - Cell Reports …, 2022 - cell.com
Parkinson's disease (PD) is a growing burden worldwide, and there is no reliable biomarker
used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients …

[HTML][HTML] Oxidative stress in Parkinson's disease: a systematic review and meta-analysis

Z Wei, X Li, X Li, Q Liu, Y Cheng - Frontiers in molecular neuroscience, 2018 - frontiersin.org
Oxidative stress has been suggested to play a key role in Parkinson's disease, but
inconsistent results were found in clinical studies. This study sought to quantitatively …

[HTML][HTML] Alpha-synuclein as a biomarker of Parkinson's disease: good, but not good enough

U Ganguly, S Singh, S Pal, S Prasad… - Frontiers in aging …, 2021 - frontiersin.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …

[HTML][HTML] Parkin clearance of dysfunctional mitochondria regulates ROS levels and increases survival of human chondrocytes

MY Ansari, NM Khan, I Ahmad, TM Haqqi - Osteoarthritis and cartilage, 2018 - Elsevier
Objective Mitochondrial dysfunction, oxidative stress and chondrocyte death are important
contributors to the development and pathogenesis of osteoarthritis (OA). In this study, we …

[HTML][HTML] Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson's disease

W Jin - Journal of clinical medicine, 2020 - mdpi.com
Brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-related kinase
receptor type B (TrkB) are widely distributed in multiple regions of the human brain …

[HTML][HTML] The neuroprotective effects of astaxanthin: therapeutic targets and clinical perspective

S Fakhri, I Yosifova Aneva, MH Farzaei… - Molecules, 2019 - mdpi.com
As the leading causes of human disability and mortality, neurological diseases affect
millions of people worldwide and are on the rise. Although the general roles of several …